IBD patients worldwide discontinuing medication due to side effect concerns 2019
As of 2019, around 46 percent of patients with ulcerative colitis worldwide reported discontinuing corticosteriod due to concerns about side effects, compared to around 41 percent of patients with Crohn's disease. This statistic illustrates the percentage of IBD patients worldwide reporting discontinuing medication due to concerns about side effects as of 2019.